Stay updated on Pembrolizumab for Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Metastatic TNBC Clinical Trial page.

Latest updates to the Pembrolizumab for Metastatic TNBC Clinical Trial page
- CheckyesterdayChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for the Help Desk.SummaryDifference0.7%
- Check8 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.0%
- Check29 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant revision.SummaryDifference0.1%
- Check59 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.0%
- Check66 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information on who can answer questions about joining the study and where it is taking place.SummaryDifference1%
Stay in the know with updates to Pembrolizumab for Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Metastatic TNBC Clinical Trial page.